Acasti Pharma Inc. Quarterly Return On Assets in % from Q4 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Acasti Pharma Inc. quarterly/annual Return On Assets history and growth rate from Q4 2020 to Q2 2024.
  • Acasti Pharma Inc. Return On Assets for the quarter ending June 30, 2024 was -15.4 %, a 64.2% increase year-over-year.
  • Acasti Pharma Inc. annual Return On Assets for 2023 was -11.6 %, a 71% increase from 2022.
  • Acasti Pharma Inc. annual Return On Assets for 2022 was -40.1 %, a 29.4% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -15.4 +27.6 +64.2% Apr 1, 2024 Jun 30, 2024
Q1 2024 -17.1 +21.3 +55.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 -50.6 -36.6 -260% Oct 1, 2023 Dec 31, 2023
Q3 2023 -46.4 -32.4 -231% Jul 1, 2023 Sep 30, 2023
Q2 2023 -43 -33.8 -367% Apr 1, 2023 Jun 30, 2023
Q1 2023 -38.4 -29.1 -314% Jan 1, 2023 Mar 31, 2023
Q4 2022 -14 -1.09 -8.41% Oct 1, 2022 Dec 31, 2022
Q3 2022 -14 +2.1 +13% Jul 1, 2022 Sep 30, 2022
Q2 2022 -9.21 +34.2 +78.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 -9.28 +52.8 +85% Jan 1, 2022 Mar 31, 2022
Q4 2021 -13 +169 +92.9% Oct 1, 2021 Dec 31, 2021
Q3 2021 -16.1 Jul 1, 2021 Sep 30, 2021
Q2 2021 -43.4 Apr 1, 2021 Jun 30, 2021
Q1 2021 -62.1 Jan 1, 2021 Mar 31, 2021
Q4 2020 -182 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.